cials, and other experts on barriers to, and best 
practices for, collecting demographic data; and 
(5) recommend policy changes that the data in-
dicates are necessary to reduce disparities. 
(d) REPORT.—Not later than 1 year after the date 
of enactment of this Act, the Commission shall submit a 
written report of its findings and recommendations to 
Congress and post such report on the website of the De-
partment of Health and Human Services. Such reports 
shall contain information concerning— 
(1) how to enhance State, local, territorial, and 
Tribal capacity to conduct public health research on 
COVID–19 and in future public health emergencies, 
with a focus on expanded capacity to analyze data 
on disparities correlated with race, ethnicity, income, 
sex, age, disability status, specific geographic areas, 
and other relevant demographic characteristics, and 
an analysis of what demographic data is currently 
being collected, the accuracy of that data and any 
gaps, how this data is currently being used to inform 
efforts to combat COVID–19, and what resources 
are needed to supplement existing public health data 
collection; 
(2) how to collect, process, and disclose to the 
public the data described in paragraph (1) in a way 
VerDate Sep 11 2014 
01:00 Mar 31, 2021
Jkt 019200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H1370.IH
H1370
pbinns on DSKJLVW7X2PROD with BILLS
that maintains individual privacy while helping di-
rect the State, local, and Tribal response to public 
health emergencies; 
(3) how to improve demographic data collection 
related to COVID–19 and other public health emer-
gencies in the short- and long-term, including how to 
continue to grow and value the Tribal sovereignty of 
data and information concerning urban and rural 
Tribal communities; 
(4) to the extent possible, an analysis of racial 
and other demographic disparities in COVID–19 
mortality, including an analysis of comorbidities and 
case fatality rates; 
(5) to the extent possible, an analysis of sex, 
gender, sexual orientation, and gender identity dis-
parities in COVID–19 treatment and mortality; 
(6) an analysis of COVID–19 treatment of indi-
viduals with disabilities, including equity of access to 
treatment and equipment and intersections of dis-
ability status with other demographic factors, includ-
ing race, and recommendations for how to improve 
transparency and equity of treatment for such indi-
viduals during the COVID–19 public health emer-
gency and future emergencies; 
VerDate Sep 11 2014 
01:00 Mar 31, 2021
Jkt 019200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H1370.IH
H1370
pbinns on DSKJLVW7X2PROD with BILLS
(7) how to support State, local, and Tribal ca-
pacity to eliminate barriers to vaccinations, testing, 
and treatment during the COVID–19 pandemic and 
future public health emergencies; and 
(8) to the extent possible, an analysis of Fed-
eral Government policies that disparately exacerbate 
the COVID–19 impact, and recommendations to im-
prove racial and other demographic disparities in 
health outcomes. 
(e) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated such sums as may be nec-
essary to carry out this section. 
Æ 
VerDate Sep 11 2014 
01:00 Mar 31, 2021
Jkt 019200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6301
E:\BILLS\H1370.IH
H1370
pbinns on DSKJLVW7X2PROD with BILLS